Save up to 30% on Elsevier print and eBooks with free shipping. No promo code needed.
Save up to 30% on print and eBooks.
Cancer Immunotherapy
1st Edition, Volume 90 - April 3, 2006
Authors: James Allison, Glen Dranoff
Language: English
Hardback ISBN:9780120224890
9 7 8 - 0 - 1 2 - 0 2 2 4 8 9 - 0
eBook ISBN:9780080463377
9 7 8 - 0 - 0 8 - 0 4 6 3 3 7 - 7
For some time immunotherapy has been heralded as a breakthrough approach for cancer treatment. Although the potential of this strategy remains solid, the approach needs…Read more
Purchase options
LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code is needed.
For some time immunotherapy has been heralded as a breakthrough approach for cancer treatment. Although the potential of this strategy remains solid, the approach needs considerable refinement. Whilst some programmes are looking to increase the understanding of molecular and cellular mechanisms underlying the stimulation of antitumor immunity, others are trying to find the most appropriate clinical setting that will reveal the role of the immune system in combating cancer. Among the most important discoveries have been tumor-specific antigens.
This thematic volume highlights some key issues and discusses where they may move forward. It has been put together by two leading cancer immunotherapists from two eminent institutions that focus on cancer research.
Immunologists, research oncologists, pathologists, and cell biologists
Engineered cellular vaccines Blockade of T cell checkpoints. Serex in the identification of target antigens New approaches to tumor immunotherapy Melanoma antigens Antibodies and chimeric molecules Tumor Immunosurveillance Dendritic Cells Strategies for Tumor Vaccination DNA vaccines
No. of pages: 400
Language: English
Edition: 1
Volume: 90
Published: April 3, 2006
Imprint: Academic Press
Hardback ISBN: 9780120224890
eBook ISBN: 9780080463377
JA
James Allison
Affiliations and expertise
Howard Hughes Medical Institute Memorial Sloan-Kettering Cancer Center, New York, U.S.A.